U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
8463184631Non Invasive Mechanical Ventilation in Chronic Respiratory Insufficiency Patients During RehabilitationRecruitingNo Results AvailableChronic Respiratory InsufficiencyOther: Daily NIV during rehabilitation|Other: Rehabilitation without NIVhttps://ClinicalTrials.gov/show/NCT01458314
8463284632Efficacy and Safety of TAK-385 in the Treatment of EndometriosisCompletedNo Results AvailableEndometriosisDrug: Placebo|Drug: TAK-385|Drug: TAK-385|Drug: TAK-385|Drug: Leuprorelin acetatehttps://ClinicalTrials.gov/show/NCT01458301
8463384633A Study to Evaluate the Safety, Pharmacokinetics, and Hematopoietic Stem Cell Mobilization of TG-0054 Alone or in Combination With G-CSF in Patients With Multiple Myeloma, Non-Hodgkin Lymphoma or Hodgkin DiseaseCompletedHas ResultsMultiple Myeloma|Non-hodgkin's Lymphoma|Hodgkin's DiseaseDrug: TG-0054https://ClinicalTrials.gov/show/NCT01458288
8463484634A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Seasonal Allergic Rhinitis (SAR)CompletedHas ResultsSeasonal Allergic RhinitisDrug: Ciclesonide nasal aerosol 37 mcg|Drug: ciclesonide nasal aerosol 74 mcg|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01458275
8463584635Observational Study on the Clinical Impact of Desaturation During Liver SurgeryCompletedNo Results AvailableCerebral DesaturationOther: systemic and cerebral oxymetryhttps://ClinicalTrials.gov/show/NCT01458262
8463684636An Open Label, Multicenter, Phase 2 Study to Evaluate the Efficacy and Safety of Eribulin Mesylate in Previously Treated Subjects With Advanced Soft Tissue Sarcoma (Study E7389-J081-217)Active, not recruitingNo Results AvailableSoft Tissue SarcomaDrug: E7389https://ClinicalTrials.gov/show/NCT01458249
8463784637A Multinational, Multicenter, Study to Assess the Efficacy and Safety of BPS-314d-MR in Subjects With Pulmonary Arterial Hypertension Currently Receiving Treatment With an Endothelin Receptor Antagonist and/or a Phosphodiesterase-5 InhibitorWithdrawnNo Results AvailablePulmonary Arterial HypertensionDrug: Beraprost Sodium 314d Modified Release Tablets|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01458236
8463884638The Effect of Prolonged Postoperative Antibiotics Administration on Rate of Infection in Patients Undergoing Posterior Spine Surgery Requiring a Hemovac DrainRecruitingNo Results AvailablePostoperative InfectionDrug: Antibiotic|Drug: Antibiotichttps://ClinicalTrials.gov/show/NCT01458223
8463984639A Study of the Effect of Dulaglutide on How the Body Handles Oral Contraceptive in Healthy Female ParticipantsCompletedHas ResultsDiabetes Mellitus, Type 2Drug: Ortho-Cyclen|Biological: Dulaglutidehttps://ClinicalTrials.gov/show/NCT01458210
8464084640A Phase 2 Study to Compare the Efficacy and Tolerability of Tarafenacin 0.2 mg and Tarafenacin 0.4 mg to Placebo in Patients Suffering From Overactive Bladder.CompletedNo Results AvailableOveractive BladderDrug: Tarafenacin 0.2 mg|Drug: Placebo|Drug: Tarafenacin 0.4 mghttps://ClinicalTrials.gov/show/NCT01458197
8464184641Study of PhoneCare System to Treat Patients With Chronic DiseasesCompletedNo Results AvailableChronic DiseaseBehavioral: PhoneCare systemhttps://ClinicalTrials.gov/show/NCT01458184
8464284642Follow-up Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study)CompletedHas ResultsPrimary Immune Deficiency DisorderBiological: Immune globulin subcutaneous (Human)https://ClinicalTrials.gov/show/NCT01458171
8464384643Matrix Metalloproteinases in Atherosclerosis of Chronic Kidney DiseaseRecruitingNo Results AvailableDiabetic Nephropathyhttps://ClinicalTrials.gov/show/NCT01458158
8464484644Minding the Baby Home Visiting: Program EvaluationActive, not recruitingNo Results AvailableAttachment|Child Maltreatment|Maternal Sensitivity|Infant HealthBehavioral: Minding the Baby Home Visiting Programhttps://ClinicalTrials.gov/show/NCT01458145
8464584645Drug Exposure Registry for GSK2248761, an Investigational NNRTIActive, not recruitingNo Results AvailableInfection, Human Immunodeficiency VirusDrug: GSK2248761https://ClinicalTrials.gov/show/NCT01458132
8464684646Open-Label Phase 3 Long-Term Safety Study of MigalastatActive, not recruitingNo Results AvailableFabry DiseaseDrug: migalastat HCl 150mghttps://ClinicalTrials.gov/show/NCT01458119
8464784647Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Recombinant Coagulation Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously Treated Pediatric Subjects With Hemophilia ACompletedHas ResultsHemophilia ADrug: BIIB031 (rFVIIIFc)|Drug: FVIII (PK subgroup only)https://ClinicalTrials.gov/show/NCT01458106
8464884648Large Overuse of Post-polypectomy Surveillance ColonoscopyCompletedNo Results AvailableColonic Polyps|Surveillance|ColonoscopyOther: colonoscopyhttps://ClinicalTrials.gov/show/NCT01458093
8464984649WEUSKOP5410: Observational Study in ENABLE Clinical TrialsCompletedNo Results AvailableHepatitis CDrug: eltrombopaghttps://ClinicalTrials.gov/show/NCT01458080
8465084650A Phase I/IIa, First Time in Human, Study of GSK2636771 in Subjects With Advanced Solid Tumors With Phosphatase and Tensin Homolog (PTEN) DeficiencyRecruitingNo Results AvailableCancerDrug: GSK2636771https://ClinicalTrials.gov/show/NCT01458067
8465184651Effect of Omeprazole and Ritonavir on GSK2336805 Pharmacokinetics in Healthy AdultsCompletedNo Results AvailableHepatitis C, ChronicDrug: Cohort 1 (GSK2336805 60mg x 1 dose, Omeprazole 40 mg q24h x 4 days, GSK2336805 60 mg x 1 dose and Omeprazole 40 mg x 1 dose)|Drug: Cohort 2 (GSK2336805 30mg x 1 dose, Ritonavir 100mg q12h x 4 days, and Ritonavir 100mg q12h x 1 dose)https://ClinicalTrials.gov/show/NCT01458054
8465284652Iloprost Therapy in Patients With Critical Limb IschemiaCompletedNo Results AvailablePeripheral Arterial DiseaseDrug: Iloprost (Ilomedin, BAYQ6256)https://ClinicalTrials.gov/show/NCT01458041
8465384653Age and Gender Effects on the Pharmacokinetics of BAY85-3934CompletedNo Results AvailableAnemiaDrug: BAY85-3934|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01458028
8465484654Tapentadol Versus Oxycodon - a Mechanism-based Treatment Approach in Neuropathic PainTerminatedNo Results AvailablePeripheral NeuropathyDrug: tapentadol, oxycodonehttps://ClinicalTrials.gov/show/NCT01458015
8465584655Online Tailored Interventions & Relational Agents for Exercise and Sun ProtectionActive, not recruitingNo Results AvailableSedentary|Skin CancerOther: Tailored Internet Communication with Relational Agent|Other: Tailored Internet Communicationshttps://ClinicalTrials.gov/show/NCT01458002
8465684656Meta-Analysis Plan for Pooled Data for Studies VRX-RET-E22-303 and VRX-RET-E22-304CompletedNo Results AvailableEpilepsy, PartialDrug: retigabine/ezogabinehttps://ClinicalTrials.gov/show/NCT01457989
8465784657A Survey on Attitudes on Financial IncentivesEnrolling by invitationNo Results AvailableObesity|Colon Cancerhttps://ClinicalTrials.gov/show/NCT01457976
8465884658Prevalence of Pulmonary Embolism in ICUCompletedNo Results AvailablePulmonary Embolism|Deep Venous Thrombosishttps://ClinicalTrials.gov/show/NCT01457963
8465984659A Study in Korean Postmenopausal Women With Osteoporosis to Evaluate the Efficacy and Safety of DenosumabCompletedHas ResultsOsteoporosis, PostmenopausalDrug: denosumab|Drug: placebo|Drug: open-label denosumabhttps://ClinicalTrials.gov/show/NCT01457950
8466084660Boceprevir/PegIFN α-2b/Riba in HCV+ Gt1 Menopausal Women, Nonresponders to PegIFN/Riba or Treatment-naives (MEN_BOC)RecruitingNo Results AvailableChronic Hepatitis C|MenopauseDrug: Pegylated Interferon, Ribavirin, Boceprevirhttps://ClinicalTrials.gov/show/NCT01457937

* Görseller ve İçerik tekif hakkına sahip olabilir